Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ANIX - Anixa advancing COVID-19 antiviral candidates to preclinical stage


ANIX - Anixa advancing COVID-19 antiviral candidates to preclinical stage

Anixa Biosciences (ANIX) and OntoChem will advance their COVID-19 antiviral candidates to the preclinical stage following successful proof-of-concept animal model study results.In the studies, the antivirals were shown to have no noticeable adverse effects, and weight impact and animal behavior was found to be similar to Gilead's Veklury (remdesivir).Anixa shares are up 5.3% to $5 in premarket trading.

For further details see:

Anixa advancing COVID-19 antiviral candidates to preclinical stage
Stock Information

Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com

Menu

ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...